Novo Nordisk launches Wegovy weight-loss drug in India: Price, dosage, and details
Novo Nordisk has officially launched its weight-loss drug Wegovy in India, following Eli Lilly's entry into the market. The once-a-week injection aims to target the high prevalence of obesity in the country, with prices starting at Rs 17,345 per injection pen. The company is optimistic about significant sales in India, given the potential user base and health benefits offered by the drug.
You can now subscribe to our Economic Times WhatsApp channel. A month after rival Eli Lilly's launch, Danish drugmaker Novo Nordisk officially launched its blockbuster weight-loss drug Wegovy on Tuesday as a once-a-week injection in India. The Danish company hopes for massive sales in India, a country where nearly 254 million people are struggling due to generalised obesity and 351 million with abdominal obesity. Novo Nordisk’s ambitious sales of $1 billion in coming years stems from its estimate that a significant proportion of them are potential users of such drugs, given the additional benefits to the heart, liver, and kidneys. The 0.25 mg, 0.5 mg, and 1 mg injection pens are priced at Rs 17,345 each, translating to Rs 4,366 per dose.
According to the source: The Economic Times.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
